248 related articles for article (PubMed ID: 25548099)
21. Downregulation of SIK2 expression promotes the melanogenic program in mice.
Horike N; Kumagai A; Shimono Y; Onishi T; Itoh Y; Sasaki T; Kitagawa K; Hatano O; Takagi H; Susumu T; Teraoka H; Kusano K; Nagaoka Y; Kawahara H; Takemori H
Pigment Cell Melanoma Res; 2010 Dec; 23(6):809-19. PubMed ID: 20819186
[TBL] [Abstract][Full Text] [Related]
22. Exploring the stability of inhibitor binding to SIK2 using molecular dynamics simulation and binding free energy calculation.
Shi M; Zhao M; Wang L; Liu K; Li P; Liu J; Cai X; Chen L; Xu D
Phys Chem Chem Phys; 2021 Jun; 23(23):13216-13227. PubMed ID: 34086021
[TBL] [Abstract][Full Text] [Related]
23. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.
Graff JR; Konicek BW; McNulty AM; Wang Z; Houck K; Allen S; Paul JD; Hbaiu A; Goode RG; Sandusky GE; Vessella RL; Neubauer BL
J Biol Chem; 2000 Aug; 275(32):24500-5. PubMed ID: 10827191
[TBL] [Abstract][Full Text] [Related]
24. The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells.
Raab M; Rak M; Tesch R; Gasimli K; Becker S; Knapp S; Strebhardt K; Sanhaji M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359562
[TBL] [Abstract][Full Text] [Related]
25. AMP-activated protein kinase phosphorylates transcription factors of the CREB family.
Thomson DM; Herway ST; Fillmore N; Kim H; Brown JD; Barrow JR; Winder WW
J Appl Physiol (1985); 2008 Feb; 104(2):429-38. PubMed ID: 18063805
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
27. Role of salt‑inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells.
Ni X; Feng Y; Fu X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558647
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.
Rao M; Zhu Y; Cong X; Li Q
Oncol Rep; 2017 Jun; 37(6):3361-3368. PubMed ID: 28498439
[TBL] [Abstract][Full Text] [Related]
29. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
[TBL] [Abstract][Full Text] [Related]
30. A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells.
Kumagai A; Horike N; Satoh Y; Uebi T; Sasaki T; Itoh Y; Hirata Y; Uchio-Yamada K; Kitagawa K; Uesato S; Kawahara H; Takemori H; Nagaoka Y
PLoS One; 2011; 6(10):e26148. PubMed ID: 22022544
[TBL] [Abstract][Full Text] [Related]
31. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
32. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2.
Horike N; Takemori H; Katoh Y; Doi J; Min L; Asano T; Sun XJ; Yamamoto H; Kasayama S; Muraoka M; Nonaka Y; Okamoto M
J Biol Chem; 2003 May; 278(20):18440-7. PubMed ID: 12624099
[TBL] [Abstract][Full Text] [Related]
33. The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes.
Henriksson E; Jones HA; Patel K; Peggie M; Morrice N; Sakamoto K; Göransson O
Biochem J; 2012 Jun; 444(3):503-14. PubMed ID: 22462548
[TBL] [Abstract][Full Text] [Related]
34. Ablation of LGR4 signaling enhances radiation sensitivity of prostate cancer cells.
Liang F; Zhang H; Cheng D; Gao H; Wang J; Yue J; Zhang N; Wang J; Wang Z; Zhao B
Life Sci; 2021 Jan; 265():118737. PubMed ID: 33171177
[TBL] [Abstract][Full Text] [Related]
35. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
[TBL] [Abstract][Full Text] [Related]
36. SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes.
Henriksson E; Säll J; Gormand A; Wasserstrom S; Morrice NA; Fritzen AM; Foretz M; Campbell DG; Sakamoto K; Ekelund M; Degerman E; Stenkula KG; Göransson O
J Cell Sci; 2015 Feb; 128(3):472-86. PubMed ID: 25472719
[TBL] [Abstract][Full Text] [Related]
37. AMP kinase promotes glioblastoma bioenergetics and tumour growth.
Chhipa RR; Fan Q; Anderson J; Muraleedharan R; Huang Y; Ciraolo G; Chen X; Waclaw R; Chow LM; Khuchua Z; Kofron M; Weirauch MT; Kendler A; McPherson C; Ratner N; Nakano I; Dasgupta N; Komurov K; Dasgupta B
Nat Cell Biol; 2018 Jul; 20(7):823-835. PubMed ID: 29915361
[TBL] [Abstract][Full Text] [Related]
38. Activation of salt-inducible kinase 2 promotes the viability of peritoneal mesothelial cells exposed to stress of peritoneal dialysis.
Wang HH; Lin CY; Su SH; Chuang CT; Chang YL; Lee TY; Lee SC; Chang CJ
Cell Death Dis; 2016 Jul; 7(7):e2298. PubMed ID: 27441650
[TBL] [Abstract][Full Text] [Related]
39. Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm.
Katoh Y; Takemori H; Min L; Muraoka M; Doi J; Horike N; Okamoto M
Eur J Biochem; 2004 Nov; 271(21):4307-19. PubMed ID: 15511237
[TBL] [Abstract][Full Text] [Related]
40. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.
Sasaki T; Takemori H; Yagita Y; Terasaki Y; Uebi T; Horike N; Takagi H; Susumu T; Teraoka H; Kusano K; Hatano O; Oyama N; Sugiyama Y; Sakoda S; Kitagawa K
Neuron; 2011 Jan; 69(1):106-19. PubMed ID: 21220102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
